Absenz Oral Solution

Absenz Oral Solution contains ethosuximide, an anticonvulsant medicine used under medical supervision to control absence seizures. The liquid formulation provides a measured alternative to capsules for patients who have been prescribed ethosuximide oral solution.

Each 1 mL contains 50 mg of ethosuximide, equivalent to 250 mg per 5 mL. Confirm the product concentration and pack details before ordering.

Product Information

Why Choose Absenz Oral Solution?

• Measured liquid formulation: Allows doses to be measured according to the prescription.

• Established active ingredient: Contains ethosuximide, used in the management of absence seizures.

• Concentration stated clearly: 50 mg/mL, equivalent to 250 mg per 5 mL.

• Product verification: Buyers can request confirmation of packaging, manufacturer, batch details and expiry information before purchase.

Price and Ordering Information

Looking for the Absenz Oral Solution price, current stock or supply options? Request a quotation with your destination country, required quantity and requested pack size.

Before confirming an order, verify:

• Current product availability and total price.

• Exact concentration, bottle size and packaging.

• Prescription and supporting documentation requirements.

• Shipping eligibility, customs rules and local import restrictions.

International supply is not guaranteed. Brand authorization, dispensing requirements and import eligibility vary by country.

Generic Ethosuximide vs. Absenz Oral Solution

Absenz is a branded oral solution containing ethosuximide. Other ethosuximide oral solutions or capsules may be available in some markets, but product names, concentrations, excipients and authorized formulations can differ.

Do not assume that another product is interchangeable solely because it contains ethosuximide. Ask a pharmacist or prescriber to confirm the appropriate formulation and concentration.

Availability by Country

This table describes markets to investigate; it does not confirm that Absenz is authorized, stocked or legally importable in each country.

Absenz Oral Solution should be taken only at the dose and frequency prescribed by a qualified healthcare professional. The appropriate regimen depends on clinical factors, including the patient's age, response and treatment plan.

Use a calibrated oral syringe or suitable medicine-measuring device. Do not estimate doses with household teaspoons. Do not discontinue ethosuximide suddenly without medical advice.

Common adverse effects can include nausea, vomiting, abdominal discomfort, reduced appetite, fatigue and dizziness. Ethosuximide can also cause rare but serious blood disorders and severe skin reactions.

Seek urgent medical attention for an unusual rash, blistering, facial swelling, breathing difficulty, persistent fever, sore throat, unexplained bruising or other signs of serious illness. Inform the prescriber about other medicines, allergies, pregnancy or breastfeeding.

Prescription use and ongoing medical monitoring are essential. Refer to the supplied product leaflet and a healthcare professional for complete safety information.